Today's

top partner

for CFD

Key Points

Many stocks in the healthcare sector are up strongly in 2026. But not health insurance giant UnitedHealth Group (NYSE: UNH). The stock is down almost 13% this year, far underperforming both the S&P 500 healthcare sector (up 1.7% this year) and the broader S&P 500 (up 0.6%). What’s going on?

Well, the company announced fourth-quarter results on Jan. 27, and investors were not impressed. UnitedHealth beat Wall Street’s expectation on earnings by a penny, which is not overly impressive. Worse, revenue of $113.2 billion came in under the consensus analyst forecast of $113.8 billion, never a good sign.

Will AI create the world’s first trillionaire? Our team just released a report on the one little-known company, called an “Indispensable Monopoly” providing the critical technology Nvidia and Intel both need. Continue »

Even worse for the share price, management’s outlook for full-year 2026 revenue was unexpectedly low. The company said it expects revenue of $439 billion, about $15 billion lower than Wall Street was expecting. If that comes to pass, it will be the company’s first annual revenue contraction in more than 30 years.

The share price plummeted 20% that day.

Disappointing news on Medicare Advantage

But that’s not all. On the very same day, the Trump administration proposed keeping federal payments to Medicare Advantage plans basically flat — with an increase in payment rates of less than 0.1% — in 2027, which is far less of an increase than what analysts and insurers expected. Industry analysts expected that the Centers for Medicare & Medicaid Services, which sets the rate, would propose an increase of between 4% and 6% for the year.

Medicare Advantage, or privately run health insurance plans contracted by Medicare, is critical to UnitedHealth’s business. In fact, the company is the largest provider of Advantage plans in the U.S., with a market share of 29%. At the end of 2025, the company served almost 9.4 million people through these plans.

So when the federal government limits growth for Advantage plans, it has a huge negative impact on Advantage plan providers.

A sign that says Medicare.

Image source: Getty Images.

In fact, the entire health insurance sector got hit by the news on Advantage payments. And it looks a lot like a government effort to end certain billing practices by Advantage providers. It’s somewhat surprising, as Wall Street analysts expected the Trump administration to be friendlier to health insurers. Instead, President Donald Trump has called the insurers “big, fat, rich,” and seems to be including them among companies that should charge consumers less.

For UnitedHealth, the news on Medicare Advantage comes at a difficult time, when the revenue outlook already looks to be softening. So it was all bad news for UnitedHealth in recent months; thus, the stock slide. I don’t expect a major improvement in the outlook anytime soon.

Should you buy stock in UnitedHealth Group right now?

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $424,262!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,163,635!*

Now, it’s worth noting Stock Advisor’s total average return is 904% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of February 21, 2026.

Matthew Benjamin has positions in Select Sector SPDR Trust-State Street Health Care Select Sector SPDR ETF. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Read the full story: Read More“>

Blog powered by G6

Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.

For any inquiries, please contact [email protected]

G6 is free to use portal to find ways to improve your life. We choose carefully posts and partner with the best in field writers to bring you the best content. Since 2006, we are there for you on your way to success.

Find on Facebook Follow on Instagram Connect on LinkedIn

Don't miss out on latest news

Join newsletter

Enable notifications

You got a story to share? Questions?

Just connect our team and let's see

©2006-2023 - All rights reserved - GSIX.ORG

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you can afford to take the high risk of losing your money

All Content on this site is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in the Site constitutes professional and/or financial advice, nor does any information on the Site constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. You alone assume the sole responsibility of evaluating the merits and risks associated with the use of any information or other Content on the Site before making any decisions based on such information or other Content. In exchange for using the Site, you agree not to hold G6, Lecira, its affiliates or any third party service provider liable for any possible claim for damages arising from any decision you make based on information or other Content made available to you through the Site.